# Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACU-4429 in Subjects With Geographic Atrophy

> **NCT01002950** · PHASE2 · COMPLETED · sponsor: **Kubota Vision Inc.** · enrollment: 72 (actual)

## Conditions studied

- Dry Age-related Macular Degeneration
- Geographic Atrophy

## Interventions

- **DRUG:** ACU-4429
- **DRUG:** Matching placebo

## Key facts

- **NCT ID:** NCT01002950
- **Lead sponsor:** Kubota Vision Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2012-06
- **Final completion:** 2012-10
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2014-03-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01002950

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01002950, "Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACU-4429 in Subjects With Geographic Atrophy". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01002950. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*